George C Eckert Ii

Array ( [id] => 10489820 [patent_doc_number] => 20150374841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'Oligonucleotide Conjugates' [patent_app_type] => utility [patent_app_number] => 14/728572 [patent_app_country] => US [patent_app_date] => 2015-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12921 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14728572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10382215 [patent_doc_number] => 20150267223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR REGULATING HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 14/724250 [patent_app_country] => US [patent_app_date] => 2015-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15845 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14724250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13168405 [patent_doc_number] => 10100308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Method for selectively inhibiting ACAT1 in the treatment of neurodegenerative diseases [patent_app_type] => utility [patent_app_number] => 15/313642 [patent_app_country] => US [patent_app_date] => 2015-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 21778 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15313642 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11969751 [patent_doc_number] => 20170273905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'LIPID MEMBRANE STRUCTURE FOR siRNA INTRACELLULAR DELIVERY' [patent_app_type] => utility [patent_app_number] => 15/311644 [patent_app_country] => US [patent_app_date] => 2015-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10200 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15311644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10353511 [patent_doc_number] => 20150238517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-27 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 14/711800 [patent_app_country] => US [patent_app_date] => 2015-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16902 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14711800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16697013 [patent_doc_number] => 10947596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Compositions and methods for identification, assessment, prevention, and treatment of cancer using NFS1 biomarkers and modulators [patent_app_type] => utility [patent_app_number] => 15/308268 [patent_app_country] => US [patent_app_date] => 2015-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 26 [patent_no_of_words] => 55500 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15308268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15306419 [patent_doc_number] => 10517890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-31 [patent_title] => Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles [patent_app_type] => utility [patent_app_number] => 15/309157 [patent_app_country] => US [patent_app_date] => 2015-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 36 [patent_no_of_words] => 27980 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15309157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11486239 [patent_doc_number] => 09592301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-14 [patent_title] => 'Compositions of matter that reduce pain, shock, and inflammation by blocking linoleic acid metabolites and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/704319 [patent_app_country] => US [patent_app_date] => 2015-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 14231 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14704319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12173091 [patent_doc_number] => 09891227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Ultrasensitive detection of a biological target by aptamer-conjugated gold nanoparticles' [patent_app_type] => utility [patent_app_number] => 14/701267 [patent_app_country] => US [patent_app_date] => 2015-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 10 [patent_no_of_words] => 6915 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13065829 [patent_doc_number] => 10053689 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-21 [patent_title] => Methods for increasing efficacy of lipid formulated siRNA [patent_app_type] => utility [patent_app_number] => 14/700938 [patent_app_country] => US [patent_app_date] => 2015-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 45458 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14700938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430646 [patent_doc_number] => 20150315659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'CIRCULATING miRNAs AS EARLY DETECTION MARKER AND PROGNOSTIC MARKER' [patent_app_type] => utility [patent_app_number] => 14/700479 [patent_app_country] => US [patent_app_date] => 2015-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 10691 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14700479 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10333561 [patent_doc_number] => 20150218564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-06 [patent_title] => 'METHOD FOR EXPRESSION OF SMALL ANTIVIRAL RNA MOLECULES WITH REDUCED CYTOTOXICITY WITHIN A CELL' [patent_app_type] => utility [patent_app_number] => 14/695462 [patent_app_country] => US [patent_app_date] => 2015-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 22152 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14695462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10468923 [patent_doc_number] => 20150353934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'Lipid Formulated Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus' [patent_app_type] => utility [patent_app_number] => 14/685271 [patent_app_country] => US [patent_app_date] => 2015-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 62911 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14685271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15282097 [patent_doc_number] => 10513706 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-24 [patent_title] => Import of unnatural or modified nucleoside triphosphates into cells via nucleic acid triphosphate transporters [patent_app_type] => utility [patent_app_number] => 15/302874 [patent_app_country] => US [patent_app_date] => 2015-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 13 [patent_no_of_words] => 48887 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15302874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10311647 [patent_doc_number] => 20150196648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-07-16 [patent_title] => 'Methods and Compositions for Treating Prostate Cancer' [patent_app_type] => utility [patent_app_number] => 14/672176 [patent_app_country] => US [patent_app_date] => 2015-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14580 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14672176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430569 [patent_doc_number] => 20150315581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'SIGNAL ACTIVATABLE CONSTRUCTS AND RELATED COMPONENTS COMPOSITIONS METHODS AND SYSTEMS' [patent_app_type] => utility [patent_app_number] => 14/641261 [patent_app_country] => US [patent_app_date] => 2015-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 40369 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14641261 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10769326 [patent_doc_number] => 20160115483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-04-28 [patent_title] => 'SILENCING OF POLO-LIKE KINASE EXPRESSION USING INTERFERING RNA' [patent_app_type] => utility [patent_app_number] => 14/638885 [patent_app_country] => US [patent_app_date] => 2015-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 66764 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14638885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11318511 [patent_doc_number] => 09517245 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-13 [patent_title] => 'Sorafenib-microRNA combination therapy for liver cancer' [patent_app_type] => utility [patent_app_number] => 14/634243 [patent_app_country] => US [patent_app_date] => 2015-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 14275 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14634243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11492610 [patent_doc_number] => 20170066796 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-09 [patent_title] => 'DNA GRIDIRON COMPOSITIONS AND METHODS' [patent_app_type] => utility [patent_app_number] => 15/121007 [patent_app_country] => US [patent_app_date] => 2015-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5482 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15121007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11480708 [patent_doc_number] => 09587239 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-07 [patent_title] => 'Methods of identifying and treating glioblastoma' [patent_app_type] => utility [patent_app_number] => 14/629431 [patent_app_country] => US [patent_app_date] => 2015-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 18266 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14629431 [rel_patent_id] =>[rel_patent_doc_number] =>)